At a time when Oregon families are reeling from higher costs on everything, including health care and prescription drugs, Attorney General Dan Rayfield and a bipartisan coalition of other states have announced a $29.6 million settlement with Glenmark, a drug manufacturer accused of inflating prices and limiting competition regarding numerous generic prescription drugs. Oregon’s share of today’s settlement is just over $316,000. 

“Every Oregonian deserves access to life-saving medicine. But corporate greed and collusion by pharmaceutical companies are sending prices out of control, forcing families to choose between medication and food. In this case, Glenmark was working with other drug companies to keep prices artificially high, and Oregon families paid for it every time they picked up a prescription. This is money out of people’s pockets for medications they needed.” – AG Rayfield